442 related articles for article (PubMed ID: 27155173)
41. Free asthma medications reduces hospital admissions in Brazil (Free asthma drugs reduces hospitalizations in Brazil).
Comaru T; Pitrez PM; Friedrich FO; Silveira VD; Pinto LA
Respir Med; 2016 Dec; 121():21-25. PubMed ID: 27888987
[TBL] [Abstract][Full Text] [Related]
42. Accessibility crisis of essential medicines at Sudanese primary healthcare facilities: a cross-sectional drugs' dispensaries assessment and patients' perspectives.
Hemmeda L; Koko AEA; Mohamed RF; Mohammed YIA; Elabid AOM; Omer AT; Hamida AARAH; Haiba AM; Ali EM; Abdelgadir II; Al Fanob RM; Almahadi SSM; Ali S; Mahgoub SAA
Int J Equity Health; 2023 Oct; 22(1):216. PubMed ID: 37848939
[TBL] [Abstract][Full Text] [Related]
43. Essential medicines are more available than other medicines around the globe.
Bazargani YT; Ewen M; de Boer A; Leufkens HG; Mantel-Teeuwisse AK
PLoS One; 2014; 9(2):e87576. PubMed ID: 24533058
[TBL] [Abstract][Full Text] [Related]
44. Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study.
Chow CK; Ramasundarahettige C; Hu W; AlHabib KF; Avezum A; Cheng X; Chifamba J; Dagenais G; Dans A; Egbujie BA; Gupta R; Iqbal R; Ismail N; Keskinler MV; Khatib R; Kruger L; Kumar R; Lanas F; Lear S; Lopez-Jaramillo P; McKee M; Mohammadifard N; Mohan V; Mony P; Orlandini A; Rosengren A; Vijayakumar K; Wei L; Yeates K; Yusoff K; Yusuf R; Yusufali A; Zatonska K; Zhou Y; Islam S; Corsi D; Rangarajan S; Teo K; Gerstein HC; Yusuf S;
Lancet Diabetes Endocrinol; 2018 Oct; 6(10):798-808. PubMed ID: 30170949
[TBL] [Abstract][Full Text] [Related]
45. Availability, Price, and Affordability of Selected Essential Medicines for Chronic Diseases in 11 Countries of the Asia Pacific Region: A Secondary Analysis.
Wang H; Sun Q; Vitry A; Nguyen TA
Asia Pac J Public Health; 2017 May; 29(4):268-277. PubMed ID: 28397532
[TBL] [Abstract][Full Text] [Related]
46. Assessing service availability and readiness to manage Chronic Respiratory Diseases (CRDs) in Bangladesh.
Paromita P; Chowdhury HA; Mayaboti CA; Rakhshanda S; Rahman AKMF; Karim MR; Mashreky SR
PLoS One; 2021; 16(3):e0247700. PubMed ID: 33661982
[TBL] [Abstract][Full Text] [Related]
47. Capacity of Ugandan public sector health facilities to prevent and control non-communicable diseases: an assessment based upon WHO-PEN standards.
Rogers HE; Akiteng AR; Mutungi G; Ettinger AS; Schwartz JI
BMC Health Serv Res; 2018 Aug; 18(1):606. PubMed ID: 30081898
[TBL] [Abstract][Full Text] [Related]
48. Availability, affordability and costs of pediatric medicines in Mongolia.
Dorj G; Sunderland B; Sanjjav T; Dorj G; Gendenragchaa B
BMC Pediatr; 2018 May; 18(1):149. PubMed ID: 29720129
[TBL] [Abstract][Full Text] [Related]
49. Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries.
Cameron A; Roubos I; Ewen M; Mantel-Teeuwisse AK; Leufkens HG; Laing RO
Bull World Health Organ; 2011 Jun; 89(6):412-21. PubMed ID: 21673857
[TBL] [Abstract][Full Text] [Related]
50. A survey of availability, price and affordability of essential medicines from 2011 to 2016 in Chinese secondary and tertiary hospitals.
Guan X; Hu H; Man C; Shi L
Int J Equity Health; 2018 Oct; 17(1):158. PubMed ID: 30340587
[TBL] [Abstract][Full Text] [Related]
51. Prices & availability of common medicines at six sites in India using a standard methodology.
Kotwani A; Ewen M; Dey D; Iyer S; Lakshmi PK; Patel A; Raman K; Singhal GL; Thawani V; Tripathi S; Laing R
Indian J Med Res; 2007 May; 125(5):645-54. PubMed ID: 17642500
[TBL] [Abstract][Full Text] [Related]
52. Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment.
Beran D; Ewen M; Lipska K; Hirsch IB; Yudkin JS
Curr Diab Rep; 2018 Jun; 18(8):48. PubMed ID: 29907884
[TBL] [Abstract][Full Text] [Related]
53. Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration.
Hogerzeil HV; Liberman J; Wirtz VJ; Kishore SP; Selvaraj S; Kiddell-Monroe R; Mwangi-Powell FN; von Schoen-Angerer T;
Lancet; 2013 Feb; 381(9867):680-9. PubMed ID: 23410612
[TBL] [Abstract][Full Text] [Related]
54. Availability of medicines in public sector health facilities of two North Indian States.
Prinja S; Bahuguna P; Tripathy JP; Kumar R
BMC Pharmacol Toxicol; 2015 Dec; 16():43. PubMed ID: 26699711
[TBL] [Abstract][Full Text] [Related]
55. Price, availability and affordability of medicines.
Mhlanga BS; Suleman F
Afr J Prim Health Care Fam Med; 2014 Jun; 6(1):E1-6. PubMed ID: 26245401
[TBL] [Abstract][Full Text] [Related]
56. Preparedness of primary and secondary health facilities in India to address major noncommunicable diseases: results of a National Noncommunicable Disease Monitoring Survey (NNMS).
Krishnan A; Mathur P; Kulothungan V; Salve HR; Leburu S; Amarchand R; Nongkynrih B; Chaturvedi HK; Ganeshkumar P; K S VU; Laxmaiah A; Boruah M; Kumar S; Patro BK; Raghav PR; Rajkumar P; Sarma PS; Sharma R; Tambe M; Arlappa N; Mahanta TG; Bhuyan PJ; Joshi RP; Pakhare AP; Galhotra A; Kumar D; Behera BK; Topno RK; Gupta MK; Rustagi N; Trivedi AV; Thankappan KR; Gupta S; Garg S; Shelke SC; ; ;
BMC Health Serv Res; 2021 Jul; 21(1):757. PubMed ID: 34332569
[TBL] [Abstract][Full Text] [Related]
57. Cost and affordability of non-communicable disease screening, diagnosis and treatment in Kenya: Patient payments in the private and public sectors.
Subramanian S; Gakunga R; Kibachio J; Gathecha G; Edwards P; Ogola E; Yonga G; Busakhala N; Munyoro E; Chakaya J; Ngugi N; Mwangi N; Von Rege D; Wangari LM; Wata D; Makori R; Mwangi J; Mwanda W;
PLoS One; 2018; 13(1):e0190113. PubMed ID: 29304049
[TBL] [Abstract][Full Text] [Related]
58. A survey of the availability, prices and affordability of essential medicines in Jiangsu Province, China.
Xi X; Li W; Li J; Zhu X; Fu C; Wei X; Chu S
BMC Health Serv Res; 2015 Aug; 15():345. PubMed ID: 26310243
[TBL] [Abstract][Full Text] [Related]
59. Medicine prices, availability, and affordability in the Shaanxi Province in China: implications for the future.
Jiang M; Zhou Z; Wu L; Shen Q; Lv B; Wang X; Yang S; Fang Y
Int J Clin Pharm; 2015 Feb; 37(1):12-7. PubMed ID: 25425142
[TBL] [Abstract][Full Text] [Related]
60. High medicine prices and poor affordability.
Suh GH
Curr Opin Psychiatry; 2011 Jul; 24(4):341-5. PubMed ID: 21532479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
